Post-radiotherapy cribriform-morular thyroid carcinoma.
J Clin Lab Anal
; 37(1): e24819, 2023 Jan.
Article
em En
| MEDLINE
| ID: mdl-36535913
ABSTRACT
BACKGROUND:
According to the new 2022 World Health Organization classification of endocrine tumors, thyroid malignancy, formerly known as the cribriform-morular variant of papillary thyroid carcinoma, is now categorized as differentiated thyroid malignancy; it is, at present, called cribriform-morular thyroid carcinoma and classified as a tumor of unknown histogenesis. CASE REPORT In this case report, we report on a 15-year-old patient who underwent external radiotherapy to the neck for Hodgkin's disease and developed cribriform-morular thyroid carcinoma 5 years after radiotherapy.CONCLUSIONS:
We believe that cribriform-morular thyroid carcinoma with diffuse nuclear beta-catenin expression has exciting and unresolved uncertainties that may affect disease prognosis and follow-up for cytopathologists and endocrinologists.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Glândula Tireoide
Tipo de estudo:
Prognostic_studies
Limite:
Adolescent
/
Humans
Idioma:
En
Revista:
J Clin Lab Anal
Assunto da revista:
TECNICAS E PROCEDIMENTOS DE LABORATORIO
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
Turquia